Digital Trends & Insights: February 2026 – A pharmaphorum industry r... February's Trends Outside the Headlines, trends & insights report showed competitive advantage is increasingly shaped by delivery, not just discovery.
Digital Trends & Insights, January 2026: A pharmaphorum industry rep... Outside of the main headlines, our new Trends & Insights report looks at the wider breadth of life sciences industry news.
Digital Agentic AI: The shift from R&D to R&P will deliver the first... The next two years will be defined by a shift from R&D (Research & Development) to R&P (Research & Prediction), facilitated by agentic AI.
Digital Key trends shaping pharmaceutical operations in 2025 2025 will be a challenging year for many sectors with multiple headwinds, and the pharmaceutical industry is no exception.
R&D Pharma holds it breath for ’25 as the sun shines on JP Morga... The JP Morgan Healthcare Conference is seen as a barometer for the life sciences industry – and, going into this year’s event, the forecast for the year was particularly grim.
Oncology Life Sciences Industry Report - Oncology Developments in the oncology space in 2024 brought hope to both industry and patients.
News TransThera's resistant biliary cancer drug cleared in China TransThera's Yochanra has been cleared in China as the world's first drug that can overcome resistance to FGFR inhibitors in cholangiocarcinoma.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.